title: [Facial inflammatory cutaneous leishmaniasis or "erysipeloid"].
authors: Service de dermatologie, 3(e) hôpital militaire, Laayoune, Maroc. Electronic address: jalalelbenaye@gmail.com.
authors: J
authors: J
authors: El Benaye
authors: Service des laboratoires, 3(e) hôpital militaire, Laayoune, Maroc.
authors: M
authors: M
authors: Miloudi
authors: Service de dermatologie, hôpital militaire Moulay Ismail, Meknès, Maroc.
authors: M
authors: M
authors: El Haouri
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D004887:Erysipeloid / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000175:diagnosis* / Q000188:drug therapy; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use; D017698:Postmenopause
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate